BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; an… Read more
Market Cap & Net Worth: BioCorRx Inc (BICX)
BioCorRx Inc (OTCQB:BICX) has a market capitalization of $8.29 Million ($8.29 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #32755 globally and #10731 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioCorRx Inc's stock price $0.35 by its total outstanding shares 23685343 (23.69 Million).
BioCorRx Inc Market Cap History: 2015 to 2025
BioCorRx Inc's market capitalization history from 2015 to 2025. Data shows change from $62.77 Million to $8.29 Million (-22.69% CAGR).
BioCorRx Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioCorRx Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
927.02x
BioCorRx Inc's market cap is 927.02 times its annual revenue
0.38x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $62.77 Million | $924.73K | -$4.67 Million | 67.87x | N/A |
| 2016 | $71.06 Million | $701.77K | -$5.90 Million | 101.25x | N/A |
| 2017 | $392.94 Million | $657.27K | -$29.71 Million | 597.84x | N/A |
| 2018 | $129.80 Million | $376.66K | -$6.51 Million | 344.60x | N/A |
| 2019 | $65.13 Million | $240.26K | -$6.04 Million | 271.10x | N/A |
| 2020 | $22.50 Million | $122.62K | -$3.51 Million | 183.50x | N/A |
| 2021 | $102.56 Million | $48.27K | -$5.21 Million | 2124.58x | N/A |
| 2022 | $23.09 Million | $213.84K | -$4.37 Million | 107.99x | N/A |
| 2023 | $18.47 Million | $89.16K | -$3.77 Million | 207.21x | N/A |
| 2024 | $7.11 Million | $7.67K | -$5.11 Million | 927.02x | N/A |
Competitor Companies of BICX by Market Capitalization
Companies near BioCorRx Inc in the global market cap rankings as of March 18, 2026.
Key companies related to BioCorRx Inc by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
BioCorRx Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, BioCorRx Inc's market cap moved from $62.77 Million to $ 8.29 Million, with a yearly change of -22.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.29 Million | +16.67% |
| 2024 | $7.11 Million | -61.54% |
| 2023 | $18.47 Million | -20.00% |
| 2022 | $23.09 Million | -77.48% |
| 2021 | $102.56 Million | +355.79% |
| 2020 | $22.50 Million | -65.45% |
| 2019 | $65.13 Million | -49.82% |
| 2018 | $129.80 Million | -66.97% |
| 2017 | $392.94 Million | +453.00% |
| 2016 | $71.06 Million | +13.21% |
| 2015 | $62.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioCorRx Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.29 Million USD |
| MoneyControl | $8.29 Million USD |
| MarketWatch | $8.29 Million USD |
| marketcap.company | $8.29 Million USD |
| Reuters | $8.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.